Back to Trades
Total Value
$NaN
Filing Date
Jun 18, 2026
1 transactions
Trade Summary
On May 18, 2026, Innovative Cellular Therapeutics Holdings Ltd, Insider, reported $NaN of Lyell Immunopharma, Inc. (LYEL) across 1 transactions. The filing covers company securities and reflects balanced net activity of $NaN. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Lyell Immunopharma, Inc.
- Ticker Symbol
- LYEL
- CIK
- 0001806952
Insider Information
- Role
- Insider
Filing Details
- Filing Date
- Jun 18, 2026
- Transaction Date
- May 18, 2026
- Accession Number
- 0001140361-26-025740
- Form Type
- 3
Want live alerts when Innovative Cellular Therapeutics Holdings Ltd trades again?
Download Insider Trades to track LYEL, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Consists of (i) 1,900,000 shares of common stock acquired by the Reporting Person on the Effective Date of the License Agreement, dated November 6, 2025, between the Issuer and the Reporting Person, as partial upfront consideration (the "Upfront Payment"), and (ii) 1,100,000 shares of common stock that the Reporting Person became entitled to receive, and acquired the right to acquire, upon the achievement of a development milestone under the License Agreement on 05/18/2026. The Reporting Person is deemed to have acquired beneficial ownership of such shares on the date its right to receive them became fixed. All shares are held of record by, and registered in the name of, the Reporting Person.